Renamic Neo
Payments companies reported to CMS as associated with Renamic Neo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Renamic Neo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Renamic Neo
These are the largest totals companies reported as associated with Renamic Neo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Guillermo Reyes | San Antonio, TX | Cardiovascular Disease | $370.33 |
| Nicholas Kotch | St Petersburg, FL | Clinical Cardiac Electrophysiology | $302.75 |
| Ki Hassler | Venice, FL | Cardiovascular Disease | $300.44 |
| Jeffrey Breneisen | Fairfield, CA | Cardiovascular Disease | $295.08 |
| Jagan Akella | Bradenton, FL | Cardiovascular Disease | $285.11 |
| Wassim Choucair | San Antonio, TX | Clinical Cardiac Electrophysiology | $223.64 |
| John Lee | Lexington, KY | Clinical Cardiac Electrophysiology | $211.82 |
| Madar Abed | Flushing, MI | Cardiovascular Disease | $211.62 |
| Christopher Bauer | Saint Louis, MO | Clinical Cardiac Electrophysiology | $200.30 |
| Antonio Moretta | Sarasota, FL | Clinical Cardiac Electrophysiology | $182.17 |
Prescribed Renamic Neo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.